Modified release Pharmaceutical formulation containing 30% - 70% of acid ethyl ester of N - (2 - amino - 4 - (fluorobencilamino) - (phenyl) carbamic retigabine)5 - 30% hydroxypropylmethylcellulose (HPMC) of a Matrix and an Enteric Polymer, method of treatment of a disorder caused by Hyper excitability of the nervous system.
Modified release Pharmaceutical formulation containing 30% - 70% of acid ethyl ester of N - (2 - amino - 4 - (fluorobencilamino) - (phenyl) carbamic retigabine)5 - 30% of a Matrix of hydroxypropylmethylcellulose (HPMC) and an Enteric Polymer, method of treatment of a disorder caused by Hyper excitability of the nervous system.<；p>；Formulació；n farmacé；utica de liberació；n modificada que contiene 30-70 % del é；ster etí；lico del á；cido n-(2-amino-4-(fluorobencilamino)-fenil)carbá；mico (retigabina), 5-30 % de una matriz de hidroxipropilmetilcelulosa (HPMC) y un polí；mero enté；rico； mé；todo de tratamiento de un trastorno provocado por hiperexcitabilidad del sistema nervioso.<；/p>；
